PI3K GENE MUTATION
Clinical trials for PI3K GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new PI3K GENE MUTATION trials appear
Sign up with your email to follow new studies for PI3K GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New precision drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug, OKI-219, designed to block a specific cancer-driving mutation (PI3KαH1047R). It is for people with advanced solid tumors or breast cancer that has not responded to other treatments. The study will first find the safest dose of OKI-219 alon…
Matched conditions: PI3K GENE MUTATION
Phase: PHASE1 • Sponsor: OnKure, Inc. • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New hope for rare blood vessel disorders: targeted drugs enter trial
Disease control Recruiting nowThis study tests two targeted drugs for people with vascular malformations (abnormal blood or lymph vessels). Participants with slow-flow malformations and a specific gene mutation receive alpelisib, while those with fast-flow malformations and another mutation receive mirdametin…
Matched conditions: PI3K GENE MUTATION
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated May 19, 2026 12:00 UTC